- Global Pharma News & Resources

Sandoz receives positive CHMP opinion for proposed biosimilar pegfilgrastim

Media release (PDF)

This announcement is distributed by West Corporation on behalf of West Corporation clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novartis International AG via GlobeNewswire

Editor Details

Last Updated: 22-Sep-2018